Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2018, Article ID 4979746, 12 pages
https://doi.org/10.1155/2018/4979746
Research Article

NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye

1Laboratory Animal Center, The Fourth Military Medical University, Xi’an, Shaanxi 710032, China
2Department of Hepatobiliary and Pancreaticosplenic Surgery, Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi 710032, China
3State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi’an, Shaanxi 710032, China

Correspondence should be addressed to Changhong Shi; nc.ude.ummf@gnohgnahc and Mengbin Li; nc.ude.ummf@nibmil

Received 30 September 2017; Revised 13 January 2018; Accepted 5 February 2018; Published 8 March 2018

Academic Editor: Fijs W. B. Van Leeuwen

Copyright © 2018 Caiqin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Hong, B.-C. Ahn, Y.-J. Jang, S. Y. Jeong, S.-W. Lee, and J. Lee, “Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma,” Clinical Nuclear Medicine, vol. 42, no. 2, pp. 95–99, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. M. K. Islam, S. Kim, H.-K. Kim et al., “Manganese Complex of Ethylenediaminetetraacetic Acid (EDTA)-Benzothiazole Aniline (BTA) Conjugate as a Potential Liver-Targeting MRI Contrast Agent,” Journal of Medicinal Chemistry, vol. 60, no. 7, pp. 2993–3001, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Miyata, T. Ishizawa, M. Kamiya et al., “Intraoperative imaging of hepatic cancers using γ-glutamyltranspeptidase-specific fluorophore enabling real-time identification and estimation of recurrence,” Scientific Reports, vol. 7, no. 1, article no. 3542, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Wu, D. Pan, and L. W. Chung, “Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer,” Translational Andrology & Urology, vol. 2, no. 3, article 254, 2013. View at Google Scholar
  5. V. Sharma, J. L. Prior, M. G. Belinsky, G. D. Kruh, and D. Piwnica-Worms, “Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: Validation in multidrug-resistant tumors and at the blood-brain barrier,” Journal of Nuclear Medicine, vol. 46, no. 2, pp. 354–364, 2005. View at Google Scholar · View at Scopus
  6. M. A. Pysz, S. S. Gambhir, and J. K. Willmann, “Molecular imaging: current status and emerging strategies,” Clinical Radiology, vol. 65, no. 7, pp. 500–516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. V. Frangioni, “In vivo near-infrared fluorescence imaging,” Current Opinion in Chemical Biology, vol. 7, no. 5, pp. 626–634, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Zhang, T. Liu, Y. Su et al., “A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging,” Biomaterials, vol. 31, no. 25, pp. 6612–6617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Wu, T.-P. Lin, J. D. Gallagher et al., “Monoamine oxidase a inhibitor-near-infrared dye conjugate reduces prostate tumor growth,” Journal of the American Chemical Society, vol. 137, no. 6, pp. 2366–2374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Yi, Y. Fei, F. Wang et al., “IR-780 Dye for Near-Infrared Fluorescence Imaging in Prostate Cancer,” Medical Science Monitor International Medical Journal of Experimental & Clinical Research, vol. 21, article 511, 2015. View at Google Scholar
  11. X. Yang, C. Shao, R. Wang et al., “Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes,” The Journal of Urology, vol. 189, no. 2, pp. 702–710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Tan, S. Luo, D. Wang, Y. Su, T. Cheng, and C. Shi, “A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties,” Biomaterials, vol. 33, no. 7, pp. 2230–2239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Shi, J. B. Wu, G. C.-Y. Chu et al., “Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis,” Oncotarget , vol. 5, no. 20, pp. 10114–10126, 2014. View at Google Scholar · View at Scopus
  14. J. B. Wu, C. Shao, X. Li et al., “Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis,” Biomaterials, vol. 35, no. 28, pp. 8175–8185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Yang, C. Shi, R. Tong et al., “Near IR heptamethine cyanine dye-mediated cancer imaging,” Clinical Cancer Research, vol. 16, no. 10, pp. 2833–2844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Shi, J. B. Wu, and D. Pan, “Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy,” Journal of Biomedical Optics, vol. 21, no. 5, Article ID 050901, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Christensen, K. Juhl, M. Persson et al., “uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: Proof-of-concept in orthotopic xenograft model,” Oncotarget , vol. 8, no. 9, pp. 15407–15419, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Takuwa, Y. Ikoma, E. Yoshida et al., “Development of a simultaneous optical/PET imaging system for awake mice,” Physics in Medicine and Biology, vol. 61, no. 17, pp. 6430–6440, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Yang and L. R. Roberts, “Hepatocellular carcinoma: a global view,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 8, pp. 448–458, 2010. View at Publisher · View at Google Scholar
  20. M. Ronot, A. K. Clift, V. Vilgrain, and A. Frilling, “Functional imaging in liver tumours,” Journal of Hepatology, vol. 65, no. 5, pp. 1017–1030, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Sun and T. Song, “Hepatocellular carcinoma: Advances in diagnostic imaging,” Drug Discoveries & Therapeutics, vol. 9, no. 5, article 310, 2015. View at Google Scholar
  22. J. An, N. Zhao, C. Zhang et al., “Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma,” Oncotarget , vol. 8, no. 34, pp. 56880–56892, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Zhao, C. Zhang, Y. Zhao et al., “Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes,” Oncotarget , vol. 7, no. 35, pp. 57277–57289, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Zhang, Y. Zhao, H. Zhang et al., “The application of heptamethine cyanine dye DZ-1 and indocyanine green for imaging and targeting in xenograft models of hepatocellular carcinoma,” International Journal of Molecular Sciences, vol. 18, no. 6, article no. 1332, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Xiao, Y. Zhang, W. Yue et al., “Heptamethine cyanine based 64Cu-PET probe PC-1001 for cancer imaging: Synthesis and in vivo evaluation,” Nuclear Medicine and Biology, vol. 40, no. 3, pp. 351–360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. V. R. Mas, D. G. Maluf, K. J. Archer et al., “Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma,” Molecular Medicine, vol. 15, no. 3-4, pp. 85–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Wurmbach, Y.-B. Chen, G. Khitrov et al., “Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma,” Hepatology, vol. 45, no. 4, pp. 938–947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Roessler, H.-L. Jia, A. Budhu et al., “A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients,” Cancer Research, vol. 70, no. 24, pp. 10202–10212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Q.-H. Ye, L.-X. Qin, M. Forgues et al., “Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning,” Nature Medicine, vol. 9, no. 4, pp. 416–423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. E. J. Heo, Y. J. Cho, W. C. Cho et al., “Patient-derived xenograft models of epithelial ovarian cancer for preclinical studies,” Cancer Research and Treatment, vol. 49, no. 4, pp. 915–926, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. J. B. Wu, C. Shi, G. C.-Y. Chu et al., “Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor,” Biomaterials, vol. 67, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Lütje, M. Rijpkema, W. Helfrich, W. J. G. Oyen, and O. C. Boerman, “Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation,” Molecular Imaging and Biology, vol. 16, no. 6, pp. 747–755, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Houghton, B. M. Zeglis, D. Abdel-Atti et al., “Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 112, no. 52, pp. 15850–15855, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Kawaguchi, Y. Nomura, M. Nagai et al., “Liver transection using indocyanine green fluorescence imaging and hepatic vein clamping,” British Journal of Surgery, vol. 104, no. 7, pp. 898–906, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kaibori, K. Matsui, M. Ishizaki et al., “Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma,” Cancer Imaging, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Gao, L. Ji, L. Li et al., “Bifunctional combined Au-Fe2O3 nanoparticles for induction of cancer cell-specific apoptosis and real-time imaging,” Biomaterials, vol. 33, no. 14, pp. 3710–3718, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Sampath, S. Kwon, M. A. Hall, R. E. Price, and E. M. Sevick-Muraca, “Detection of cancer metastases with a dual-labeled near- infrared/positron emission tomography imaging agent,” Translational Oncology, vol. 3, no. 5, pp. 307–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zhang, L. Xiao, K. Popovic et al., “Novel cancer-targeting SPECT/NIRF dual-modality imaging probe 99mTc-PC-1007: Synthesis and biological evaluation,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 23, pp. 6350–6354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Siolas and G. J. Hannon, “Patient-derived tumor xenografts: transforming clinical samples into mouse models,” Cancer Research, vol. 73, no. 17, pp. 5315–5319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Shao, W. Liang, F. Kang et al., “A direct comparison of tumor angiogenesis with 68Ga-labeled NGR and RGD peptides in HT-1080 tumor xenografts using microPET imaging,” Amino Acids, vol. 46, no. 10, pp. 2355–2364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. P. J. Riss, C. Burchardt, and F. Roesch, “A methodical 68Ga-labelling study of DO2A-(butyl- l-tyrosine)2 with cation-exchanger post-processed 68Ga: Practical aspects of radiolabelling,” Contrast Media & Molecular Imaging, vol. 6, no. 6, pp. 492–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Liu and Q. Li, “Organic anion-transporting polypeptides: A novel approach for cancer therapy,” Journal of Drug Targeting, vol. 22, no. 1, pp. 14–22, 2014. View at Publisher · View at Google Scholar · View at Scopus